机译:Selumetinib (koselugo0) in plexiform neurofibromas due to neurofibromatosis type 1: Often a reduction in tumour size, but without evidence of clinical improvement
机译:Anifrolumab (saphnelo0) In systemic lupus erythematosus after failure of standard therapy: Avoid burdening patients with an additional treatment whose clinical efficacy has not been adequately demonstrated